Download the agenda here:
All financial incentives will be disclosed. TMC require all speaker disclosures and conflicts of interest to be supplied upon request.
TMC activities are developed in conjunction with expert faculty. Unapproved products or unapproved uses of approved products may be discussed by the faculty; these situations may reflect the approval status in one or more jurisdictions. The presenting faculty have been advised by TMC to ensure that they disclose any such references made to unlabeled or unapproved use. No endorsement by TMC of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in TMC activities. TMC accepts no responsibility for errors or omissions.
The views and opinions expressed are those of the faculty and do not necessarily reflect those of any sponsor.
This activity has been sponsored by GW Pharmaceuticals, plc, who provided financial support and has had input into the selection of the faculty and/or the detailed project scope.
This activity is provided by Touch Medical Communications (TMC) for touchNEUROLOGY.
Veeva code: VV-MED-15731
Date of preparation: 27/11/2020
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!